Home
TNXP
TNXP News

Latest Tonix Pharmaceuticals Holding Corp. (TNXP) News on April 2, 2025

Tonix Pharmaceuticals Launches TONIX ONE™, a Fully-Integrated Digital Platform Designed to Help Patients Better Understand and Manage Their Migraine Condition

GlobeNewswire

a day ago

Tonix Pharmaceuticals Launches TONIX ONE™, a Fully-Integrated Digital Platform Designed to Help Patients Better Understand and Manage Their Migraine Condition

Tonix’s Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year

ACCESS Newswire

2 days ago

Tonix’s Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year

ACCESS Newswire

4 days ago

New to The Street Show #639 Premieres Nationwide on Bloomberg Television, March 29 at 6:30 PM EST Featuring BioVie, Roadzen, Tonix Pharma, and eXoZymes Inc.

Tonix Pharmaceuticals Announces Presentation at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting

GlobeNewswire

6 days ago

Tonix Pharmaceuticals Announces Presentation at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting

MT Newswires

9 days ago

Sector Update: Health Care Stocks Higher in Afternoon Trading

MT Newswires

9 days ago

Sector Update: Health Care

MT Newswires

9 days ago

Update: Tonix Pharmaceuticals Says US FDA Will Not Require Committee Meeting to Discuss NDA for Fibromyalgia Treatment; Shares Up

MT Newswires

9 days ago

Sector Update: Health Care Stocks Edge Higher Premarket Monday

MT Newswires

9 days ago

Tonix Pharmaceuticals Says US FDA Will Not Require Committee Meeting to Discuss NDA for Fibromyalgia Treatment

Tonix Pharmaceuticals Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for TNX-102 SL for the Management of Fibromyalgia

GlobeNewswire

9 days ago

Tonix Pharmaceuticals Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for TNX-102 SL for the Management of Fibromyalgia

As Mpox Cases Spread Around the World, Tonix Pharmaceuticals’ Single-Dose Vaccine TNX-801 Has Potential to Slow the Spread

ACCESS Newswire

13 days ago

As Mpox Cases Spread Around the World, Tonix Pharmaceuticals’ Single-Dose Vaccine TNX-801 Has Potential to Slow the Spread

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

GlobeNewswire

15 days ago

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing

GlobeNewswire

19 days ago

Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing

Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring 2025

GlobeNewswire

20 days ago

Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring 2025

Life Sciences Investor Forum Agenda Announced for March 13th

GlobeNewswire

21 days ago

Life Sciences Investor Forum Agenda Announced for March 13th

Tonix’s TNX-1500 Shows Promise in Preventing Organ Transplant Rejections of Either Human or Pig Organs; Autoimmune Diseases Also a Target

ACCESS Newswire

21 days ago

Tonix’s TNX-1500 Shows Promise in Preventing Organ Transplant Rejections of Either Human or Pig Organs; Autoimmune Diseases Also a Target

Tonix Pharmaceuticals to Present at the Zacks SCR Life Sciences Virtual Investor Forum on March 13th

GlobeNewswire

22 days ago

Tonix Pharmaceuticals to Present at the Zacks SCR Life Sciences Virtual Investor Forum on March 13th

Tonix Pharmaceuticals Announces Grant by Medical CBRN Defense Consortium (MCDC) for Development of TNX-801, the Company’s Single-Dose Mpox and Smallpox Vaccine Candidate

GlobeNewswire

23 days ago

Tonix Pharmaceuticals Announces Grant by Medical CBRN Defense Consortium (MCDC) for Development of TNX-801, the Company’s Single-Dose Mpox and Smallpox Vaccine Candidate

Why Tonix Pharmaceuticals Holding Corp. (TNXP) Soared Last Week

Insider Monkey

23 days ago

Why Tonix Pharmaceuticals Holding Corp. (TNXP) Soared Last Week

Why Tonix Pharmaceuticals Holding Corp. (TNXP) Soared on Thursday

Insider Monkey

a month ago

Why Tonix Pharmaceuticals Holding Corp. (TNXP) Soared on Thursday

A 41% Surge? This Small-Cap Pharma Stock Just Shook Up the Fibromyalgia Market

GuruFocus.com

a month ago

A 41% Surge? This Small-Cap Pharma Stock Just Shook Up the Fibromyalgia Market

Tonix Surges 31% Following Positive Phase 3 Fibromyalgia Drug Trial Results

GuruFocus.com

a month ago

Tonix Surges 31% Following Positive Phase 3 Fibromyalgia Drug Trial Results

Tonix Pharmaceuticals to Present at the 2025 Virtual Investor Summit

GlobeNewswire

a month ago

Tonix Pharmaceuticals to Present at the 2025 Virtual Investor Summit

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at 7th International Congress on Controversies in Fibromyalgia

GlobeNewswire

a month ago

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at 7th International Congress on Controversies in Fibromyalgia

TNXP: PDUFA Date for TNX-102 SL in Fibromyalgia of August 15, 2025…

Zacks Small Cap Research

a month ago

TNXP: PDUFA Date for TNX-102 SL in Fibromyalgia of August 15, 2025…

MT Newswires

2 months ago

Tonix Pharmaceuticals Rises After Preliminary 2024 Results

Tonix Pharmaceuticals reports positive topline trial outcomes of TNX-1500

Clinical Trials Arena

2 months ago

Tonix Pharmaceuticals reports positive topline trial outcomes of TNX-1500

Tonix Pharmaceuticals Recently Announced Preliminary Full Year 2024 Operating Results and Year-End Cash

GlobeNewswire

2 months ago

Tonix Pharmaceuticals Recently Announced Preliminary Full Year 2024 Operating Results and Year-End Cash

Tonix Pharmaceuticals Announces Positive Topline Results from Phase 1 Trial for TNX-1500, a Next Generation anti-CD40L mAb Candidate for Prevention of Kidney Transplant Rejection and Treatment of Autoimmune Diseases

GlobeNewswire

2 months ago

Tonix Pharmaceuticals Announces Positive Topline Results from Phase 1 Trial for TNX-1500, a Next Generation anti-CD40L mAb Candidate for Prevention of Kidney Transplant Rejection and Treatment of Autoimmune Diseases

Tonix Pharmaceuticals to Participate in the 2025 BIO CEO & Investor Conference

GlobeNewswire

2 months ago

Tonix Pharmaceuticals to Participate in the 2025 BIO CEO & Investor Conference

Tonix Pharmaceuticals Promotes Siobhan Fogarty to Chief Technical Officer

GlobeNewswire

2 months ago

Tonix Pharmaceuticals Promotes Siobhan Fogarty to Chief Technical Officer

Tonix Pharmaceuticals Announces 1-for-100 Reverse Stock Split

GlobeNewswire

2 months ago

Tonix Pharmaceuticals Announces 1-for-100 Reverse Stock Split

Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Gary Ainsworth as Vice President of Market Access

GlobeNewswire

3 months ago

Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Gary Ainsworth as Vice President of Market Access

Tonix Pharmaceuticals to Present at Two Upcoming January Investor Conferences

GlobeNewswire

3 months ago

Tonix Pharmaceuticals to Present at Two Upcoming January Investor Conferences

MT Newswires

3 months ago

Tonix Pharmaceuticals Says FDA Set Target Action Date for Potential Fibromyalgia Drug

Tonix Pharmaceuticals Announces PDUFA Goal Date of August 15, 2025, for FDA Decision on U.S. Marketing Approval for TNX-102 SL for Fibromyalgia

GlobeNewswire

3 months ago

Tonix Pharmaceuticals Announces PDUFA Goal Date of August 15, 2025, for FDA Decision on U.S. Marketing Approval for TNX-102 SL for Fibromyalgia

MT Newswires

4 months ago

Tonix Pharmaceuticals Shares Jump After FDA Accepts NDA for Fibromyalgia Drug

Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia

GlobeNewswire

4 months ago

Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia

Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights

GlobeNewswire

4 months ago

Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights

Tonix's TNX 102-SL Could Offer New Hope of Pain Relief Without Narcotics for Fibromyalgia Sufferers

ACCESSWIRE

4 months ago

Tonix's TNX 102-SL Could Offer New Hope of Pain Relief Without Narcotics for Fibromyalgia Sufferers

Tonix Pharmaceuticals Announces Expansion of Leadership Team with Two Strategic Hires

GlobeNewswire

4 months ago

Tonix Pharmaceuticals Announces Expansion of Leadership Team with Two Strategic Hires

TNXP: NDA Filed for TNX-102 SL in Fibromyalgia…

Zacks Small Cap Research

4 months ago

TNXP: NDA Filed for TNX-102 SL in Fibromyalgia…

Tonix Pharmaceuticals to Participate in the NobleCon20 Investor Conference

GlobeNewswire

4 months ago

Tonix Pharmaceuticals to Participate in the NobleCon20 Investor Conference

Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual

GlobeNewswire

4 months ago

Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting

GlobeNewswire

4 months ago

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting

Tonix Pharmaceuticals Targets Rapid Migraine Relief With Non-Oral Treatments

ACCESSWIRE

5 months ago

Tonix Pharmaceuticals Targets Rapid Migraine Relief With Non-Oral Treatments

Tonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting

GlobeNewswire

5 months ago

Tonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting

Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company’s Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised Animals

GlobeNewswire

5 months ago

Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company’s Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised Animals

Tonix Pharma Partners for Vaccine Clinical Trial

TipRanks

5 months ago

Tonix Pharma Partners for Vaccine Clinical Trial

Tonix Pharmaceuticals Announces Research Agreement with Kenya Medical Research Institute (KEMRI) to Design, Plan and Seek Regulatory Approval for a Phase I Clinical Study of TNX-801 for Mpox in Kenya

GlobeNewswire

5 months ago

Tonix Pharmaceuticals Announces Research Agreement with Kenya Medical Research Institute (KEMRI) to Design, Plan and Seek Regulatory Approval for a Phase I Clinical Study of TNX-801 for Mpox in Kenya

Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress-Europe 2024

GlobeNewswire

5 months ago

Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress-Europe 2024

Tonix Pharmaceuticals to Present at BIO-Europe® 2024

GlobeNewswire

5 months ago

Tonix Pharmaceuticals to Present at BIO-Europe® 2024

Tonix Pharmaceuticals to Present at the 2024 ThinkEquity Conference

GlobeNewswire

5 months ago

Tonix Pharmaceuticals to Present at the 2024 ThinkEquity Conference

Tonix Pharmaceuticals Announces Oral Presentation at the World Vaccine Congress Europe 2024

GlobeNewswire

5 months ago

Tonix Pharmaceuticals Announces Oral Presentation at the World Vaccine Congress Europe 2024

MT Newswires

6 months ago

Tonix Pharmaceuticals Shares Surge After 1st Payment From Defense Department

Tonix Pharmaceuticals Receives First Contract Payment from U.S. Department of Defense for Accelerated Development of Broad-Spectrum Antivirals with the Defense Threat Reduction Agency (DTRA)

GlobeNewswire

6 months ago

Tonix Pharmaceuticals Receives First Contract Payment from U.S. Department of Defense for Accelerated Development of Broad-Spectrum Antivirals with the Defense Threat Reduction Agency (DTRA)

Empery Asset Management LP Acquires Shares in Tonix Pharmaceuticals

GuruFocus.com

6 months ago

Empery Asset Management LP Acquires Shares in Tonix Pharmaceuticals

MT Newswires

6 months ago

Tonix Pharmaceuticals Files New Drug Application With FDA for TNX-102 SL to Treat Fibromyalgia

Tonix Pharmaceuticals Announces Submission of the TNX-102 SL New Drug Application (NDA) for Fibromyalgia to the U.S. Food and Drug Administration (FDA)

GlobeNewswire

6 months ago

Tonix Pharmaceuticals Announces Submission of the TNX-102 SL New Drug Application (NDA) for Fibromyalgia to the U.S. Food and Drug Administration (FDA)

Tonix Pharma Enhances Drug Development with AI Partnership

TipRanks

6 months ago

Tonix Pharma Enhances Drug Development with AI Partnership

Tonix Pharmaceuticals Announces AI Collaboration with X-Chem to Develop Broad-Spectrum Antivirals

GlobeNewswire

6 months ago

Tonix Pharmaceuticals Announces AI Collaboration with X-Chem to Develop Broad-Spectrum Antivirals

The Rush for Non-Addictive Painkillers to Counter the Opioid Crisis Puts Two Companies Close to FDA Decisions

ACCESSWIRE

6 months ago

The Rush for Non-Addictive Painkillers to Counter the Opioid Crisis Puts Two Companies Close to FDA Decisions

Tonix Pharmaceuticals Announces Participation in Endpoints Panel at the Long COVID Workshop and RECOVER TLC Workshop Convened by the Foundation for the National Institutes of Health (FNIH) and the National Institute of Allergy and Infectious Diseases (NIAID)

GlobeNewswire

6 months ago

Tonix Pharmaceuticals Announces Participation in Endpoints Panel at the Long COVID Workshop and RECOVER TLC Workshop Convened by the Foundation for the National Institutes of Health (FNIH) and the National Institute of Allergy and Infectious Diseases (NIAID)

MT Newswires

6 months ago

Tonix Pharmaceuticals Receives US Patent for Migraine Treatment; Shares Rise

Tonix Pharmaceuticals Announces Issuance of U.S. Patent Covering the Subcutaneous Delivery of FDA-Approved Zembrace® SymTouch® to Treat Migraines

GlobeNewswire

6 months ago

Tonix Pharmaceuticals Announces Issuance of U.S. Patent Covering the Subcutaneous Delivery of FDA-Approved Zembrace® SymTouch® to Treat Migraines

Tonix Pharmaceuticals Announces Data Presentations on TNX-102 SL for Fibromyalgia at the 11th Global Conference on Pharmaceutics and Novel Drug Delivery Systems (PDDS 2024)

GlobeNewswire

6 months ago

Tonix Pharmaceuticals Announces Data Presentations on TNX-102 SL for Fibromyalgia at the 11th Global Conference on Pharmaceutics and Novel Drug Delivery Systems (PDDS 2024)

MT Newswires

6 months ago

Tonix Pharmaceuticals Secures US Patent for Migraine Treatment -- Shares Rise Pre-Bell

Tonix Pharmaceuticals Announces Issuance of U.S. Patent by the United States Patent and Trademark Office Covering the Intranasal Delivery of FDA-Approved Tosymra® to Treat Migraines

GlobeNewswire

6 months ago

Tonix Pharmaceuticals Announces Issuance of U.S. Patent by the United States Patent and Trademark Office Covering the Intranasal Delivery of FDA-Approved Tosymra® to Treat Migraines

New Hope for Mpox? How TNX-801 Could Meet the WHO's Vaccine Targets for a Safer, Single-Dose Solution

ACCESSWIRE

6 months ago

New Hope for Mpox? How TNX-801 Could Meet the WHO's Vaccine Targets for a Safer, Single-Dose Solution

GlobeNewswire

7 months ago

Tonix Pharmaceuticals Announces That its Single Dose Mpox Vaccine Candidate TNX-801 Aligns with WHO’s Newly Issued Preferred Target Product Profile for Mpox Vaccines in Global Health Emergency

Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing

ACCESSWIRE

7 months ago

Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing

Tonix Pharmaceuticals Announces Appointment of Thomas Englese as Executive Vice President of Commercial Operations

GlobeNewswire

7 months ago

Tonix Pharmaceuticals Announces Appointment of Thomas Englese as Executive Vice President of Commercial Operations

TNXP: Mpox Declared a Public Health Emergency of International Concern by World Health Organization…

Zacks Small Cap Research

7 months ago

TNXP: Mpox Declared a Public Health Emergency of International Concern by World Health Organization…

MT Newswires

7 months ago

Tonix Pharmaceuticals Says Mpox Vaccine Effective in Animal Tests

Tonix Pharmaceuticals Presented Data on the Potential Mpox Vaccine TNX-801 in “Using Synthetic Biology to Battle Mpox” Talk at Immunology Symposium at the University of Alberta

GlobeNewswire

7 months ago

Tonix Pharmaceuticals Presented Data on the Potential Mpox Vaccine TNX-801 in “Using Synthetic Biology to Battle Mpox” Talk at Immunology Symposium at the University of Alberta

Tonix Pharmaceuticals Launches National Awareness Campaign on the Impact of Gastroparesis or Stomach Paralysis on the Absorption of Oral Migraine Medications at PAINWeek

GlobeNewswire

7 months ago

Tonix Pharmaceuticals Launches National Awareness Campaign on the Impact of Gastroparesis or Stomach Paralysis on the Absorption of Oral Migraine Medications at PAINWeek

As Research into Pain Accelerates, a Newly Recognized Type of Pain Comes to the Forefront - Tonix Targets it with FDA-Fast Track-Designated TNX-102 SL

ACCESSWIRE

7 months ago

As Research into Pain Accelerates, a Newly Recognized Type of Pain Comes to the Forefront - Tonix Targets it with FDA-Fast Track-Designated TNX-102 SL

Tonix Pharmaceuticals Presented Data from Two Posters on TNX-102 SL for Reduction of Acute Stress Reaction and Prevention of PTSD and One Poster for Wound Healing at the 2024 Military Health System Research Symposium (MHSRS)

GlobeNewswire

7 months ago

Tonix Pharmaceuticals Presented Data from Two Posters on TNX-102 SL for Reduction of Acute Stress Reaction and Prevention of PTSD and One Poster for Wound Healing at the 2024 Military Health System Research Symposium (MHSRS)

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the 2024 Military Health System Research Symposium (MHSRS)

GlobeNewswire

7 months ago

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the 2024 Military Health System Research Symposium (MHSRS)

Tonix Pharma Collaborates With World's Largest Vaccine Manufacturer For Mpox Vaccine

Benzinga

7 months ago

Tonix Pharma Collaborates With World's Largest Vaccine Manufacturer For Mpox Vaccine

Tonix Pharmaceuticals and Bilthoven Biologicals to Collaborate on Advancing Development of Tonix’s Mpox Vaccine, TNX-801

GlobeNewswire

7 months ago

Tonix Pharmaceuticals and Bilthoven Biologicals to Collaborate on Advancing Development of Tonix’s Mpox Vaccine, TNX-801

Modern Twist to Centuries-Old Smallpox Vaccine Poised to Combat Deadly Mpox Strain as WHO Declares Global Emergency

ACCESSWIRE

7 months ago

Modern Twist to Centuries-Old Smallpox Vaccine Poised to Combat Deadly Mpox Strain as WHO Declares Global Emergency

Tonix Pharmaceuticals Announces Oral Presentation and Three Poster Presentations at the 2024 Military Health System Research Symposium (MHSRS)

GlobeNewswire

7 months ago

Tonix Pharmaceuticals Announces Oral Presentation and Three Poster Presentations at the 2024 Military Health System Research Symposium (MHSRS)

Tonix initiates Phase II trial for emergency cocaine intoxication treatment

Clinical Trials Arena

7 months ago

Tonix initiates Phase II trial for emergency cocaine intoxication treatment

MT Newswires

7 months ago

Tonix Pharmaceuticals Begins Phase 2 Trial of Cocaine Intoxication Treatment

Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 CATALYST Study of TNX-1300 for the Treatment of Cocaine Intoxication

GlobeNewswire

7 months ago

Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 CATALYST Study of TNX-1300 for the Treatment of Cocaine Intoxication

MT Newswires

7 months ago

Tonix Pharmaceuticals Holding's Q2 Loss Narrows, Revenue Rises

MT Newswires

7 months ago

Top Premarket Gainers

Tonix Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational Highlights

GlobeNewswire

7 months ago

Tonix Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational Highlights

Tonix Pharmaceuticals' Live Virus Vaccine Candidate Shows Long-Term Protection From Mpox, Smallpox With 1 Dose, Animal Study Suggests

Benzinga

8 months ago

Tonix Pharmaceuticals' Live Virus Vaccine Candidate Shows Long-Term Protection From Mpox, Smallpox With 1 Dose, Animal Study Suggests

Tonix Pharmaceuticals Provides Update on the Development of Its Single Dose Live Attenuated Virus Vaccine Candidate for Mpox, TNX-801, as WHO Declares Mpox Outbreak a Global Health Emergency

GlobeNewswire

8 months ago

Tonix Pharmaceuticals Provides Update on the Development of Its Single Dose Live Attenuated Virus Vaccine Candidate for Mpox, TNX-801, as WHO Declares Mpox Outbreak a Global Health Emergency

Tonix Pharmaceuticals to Present at the Summer 2024 Virtual Investor Summit

GlobeNewswire

8 months ago

Tonix Pharmaceuticals to Present at the Summer 2024 Virtual Investor Summit

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia, the Prototypic Nociplastic Pain Syndrome, at the IASP 2024 World Congress on Pain

GlobeNewswire

8 months ago

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia, the Prototypic Nociplastic Pain Syndrome, at the IASP 2024 World Congress on Pain

Tonix Pharmaceuticals Announces Publication in Microorganisms of Technology that Expands Company’s Capabilities in Generating Potential Therapeutic Fully Human Antibodies Against SARS-CoV-2 and Other Pathogens

GlobeNewswire

8 months ago

Tonix Pharmaceuticals Announces Publication in Microorganisms of Technology that Expands Company’s Capabilities in Generating Potential Therapeutic Fully Human Antibodies Against SARS-CoV-2 and Other Pathogens

FDA Recognizes Fibromyalgia as a 'Serious Condition' And Fast-Tracks New Drug Candidate

ACCESSWIRE

8 months ago

FDA Recognizes Fibromyalgia as a 'Serious Condition' And Fast-Tracks New Drug Candidate

Tonix Pharmaceuticals Announces Potential Positive Impact of the U.S. National Academies (NASEM) New Definition of Long COVID on the Size of the Fibromyalgia Market for Tonmya™

GlobeNewswire

8 months ago

Tonix Pharmaceuticals Announces Potential Positive Impact of the U.S. National Academies (NASEM) New Definition of Long COVID on the Size of the Fibromyalgia Market for Tonmya™

Tonix Pharmaceuticals Announces Poster Presentation at the IASP 2024 World Congress on Pain

GlobeNewswire

8 months ago

Tonix Pharmaceuticals Announces Poster Presentation at the IASP 2024 World Congress on Pain

MT Newswires

8 months ago

Tonix Pharmaceuticals Gets FDA Fast Track Label For Tonmya; Shares Rise

Tonix Pharmaceuticals Granted Fast Track Designation by FDA for Tonmya™ for Fibromyalgia

GlobeNewswire

8 months ago

Tonix Pharmaceuticals Granted Fast Track Designation by FDA for Tonmya™ for Fibromyalgia

MT Newswires

8 months ago

Tonix Pharmaceuticals Signs Deal with US Defense Department to Develop Antiviral Drugs

Share on Social Networks: